Uncategorized

KPI Therapeutics Announces Expanded Drug Programs in Eye and Skin Diseases

by Business Wire • 2016/02/08 • 0 Comments

SEATTLE--(BUSINESS WIRE)--KPI Therapeutics initiates two new lines of research

← Ladas Super Surface dinâmica ajuda a otimizar e refinar os cálculos da LIO

Glaukos Establishes Direct Sales Organization and Launches iStent inject® Trabecular Micro-Bypass Stent in Australia →